Gene · 29978
Papers1,439
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,439
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| NRF2 signaling cascade in amyotrophic lateral sclerosis: bridging the gap between promise and reality. | Neural Regen Res | 2024 | 37862202 | PubTator, text mining | PubMed |
| A Machine Learning Approach for Highlighting microRNAs as Biomarkers Linked to Amyotrophic Lateral Sclerosis Diagnosis and Progression. | Biomolecules | 2023 | 38254647 | PubTator, text mining | PubMed |
| Simple models to understand complex disease: 10 years of progress from Caenorhabditis elegans models of amyotrophic lateral sclerosis and frontotemporal lobar degeneration. | Front Neurosci | 2023 | 38239833 | PubTator, text mining | PubMed |
| Genetic Interactions of Progranulin Across the ALS-FTD Spectrum and Beyond. | MicroPubl Biol | 2023 | 38188422 | PubTator, text mining | PubMed |
| Fundamental roles of the Optineurin gene in the molecular pathology of Amyotrophic Lateral Sclerosis. | Front Neurosci | 2023 | 38178841 | PubTator, text mining | PubMed |
| The genetic puzzle of a SOD1-patient with ocular ptosis and a motor neuron disease: a case report. | Front Genet | 2023 | 38152653 | PubTator, text mining | PubMed |
| Phase Separation as a Driver of Stem Cell Organization and Function during Development. | J Dev Biol | 2023 | 38132713 | PubTator, text mining | PubMed |
| Exploring epigenetic drift and rare epivariations in amyotrophic lateral sclerosis by epigenome-wide association study. | Front Aging Neurosci | 2023 | 38090719 | PubTator, text mining | PubMed |
| A pilot study on the immune cell proteome of long COVID patients shows changes to physiological pathways similar to those in myalgic encephalomyelitis/chronic fatigue syndrome. | Sci Rep | 2023 | 38086949 | PubTator, text mining | PubMed |
| MicroRNAs as Potential Biomarkers of Environmental Exposure to Polycyclic Aromatic Hydrocarbons and Their Link with Inflammation and Lung Cancer. | Int J Mol Sci | 2023 | 38069307 | PubTator, text mining | PubMed |
| Mitochondrial Dyshomeostasis as an Early Hallmark and a Therapeutic Target in Amyotrophic Lateral Sclerosis. | Int J Mol Sci | 2023 | 38069154 | PubTator, text mining | PubMed |
| Targeting Proteasomes and the MHC Class I Antigen Presentation Machinery to Treat Cancer, Infections and Age-Related Diseases. | Cancers (Basel) | 2023 | 38067336 | PubTator, text mining | PubMed |
| Meeting report: transposable elements at the crossroads of evolution, health and disease 2023. | Mob DNA | 2023 | 38012685 | PubTator, text mining | PubMed |
| Pharmacogenomics of Dementia: Personalizing the Treatment of Cognitive and Neuropsychiatric Symptoms. | Genes (Basel) | 2023 | 38002991 | PubTator, text mining | PubMed |
| ALS/FTD-associated mutation in cyclin F inhibits ER-Golgi trafficking, inducing ER stress, ERAD and Golgi fragmentation. | Sci Rep | 2023 | 37993492 | PubTator, text mining | PubMed |
| CD47: The Next Frontier in Immune Checkpoint Blockade for Non-Small Cell Lung Cancer. | Cancers (Basel) | 2023 | 37958404 | PubTator, text mining | PubMed |
| Targeting nucleic acid phase transitions as a mechanism of action for antimicrobial peptides. | Nat Commun | 2023 | 37935659 | PubTator, text mining | PubMed |
| Reduction of oligomer size modulates the competition between cluster formation and phase separation of the tumor suppressor SPOP. | J Biol Chem | 2023 | 37926283 | PubTator, text mining | PubMed |
| In silico SNP prediction of selected protein orthologues in insect models for Alzheimer's, Parkinson's, and Huntington's diseases. | Sci Rep | 2023 | 37923901 | PubTator, text mining | PubMed |
| Rational therapeutic targets with biomolecular liquid-liquid phase separation regulating synergy: A pan-cancer analysis. | PLoS One | 2023 | 37917664 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/29978/papers?page=4